Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1,215

Dogs are amazing, and we all know it.

Dogs do a lot for us. They sniff out diseases, lead those who are blind or visually impaired, and search for humans in disaster areas. And it would come as no surprise if we told you that they could detect stress through humans’ sweat and breath, as well.

Researchers from Queen’s University, Belfast, collected sweat and breath samples of 36 participants before and after they handled a tense mental arithmetic task.

Queen’s University Belfast.

A recent study published in the journal PLOS ONE has revealed just that.

Read more | >

Including decaffeinated and instant ones.

A new study conducted by Australian scientists suggests that consuming two to three cups of decaffeinated, ground, and instant coffee can lower the risk of developing cardiovascular disease and dying early.

“In this large, observational study, ground, instant, and decaffeinated coffee were associated with equivalent reductions in the incidence of cardiovascular disease and death from cardiovascular disease or any cause,” says study author Professor Peter Kistler of the Baker Heart and Diabetes Research Institute in a media release.

“The results suggest that mild to moderate intake of ground, instant, and decaffeinated coffee should be considered part of a healthy lifestyle.”

Full Story:

SB/iStock.

Continue reading “Drinking 2 to 3 cups of coffee per day could have a surprising effect on longevity” | >

In adult mice with loss of CHD8 gene function, FDA-approved drug partially restores disrupted brain cell production

CINCINNATI, Sept. 23, 2022 /PRNewswire/ — Research led by a scientist at Cincinnati Children’s who primarily studies brain tumors may open doors for improved treatment of autism.

Autism spectrum disorder (ASD) affects about one in 40 children between ages 3 and 17, according to the National Survey of Children’s Health. Those affected often experience difficulty socializing, impaired language development, repetitive behaviors, and other symptoms. Of those tested for various genes linked to the condition, nearly everyone with disruptive mutations of the gene CHD8 has autism.

Read more | >

Advancements in 3D printing have made it easier for designers and engineers to customize projects, create physical prototypes at different scales, and produce structures that can’t be made with more traditional manufacturing techniques. But the technology still faces limitations—the process is slow and requires specific materials which, for the most part, must be used one at a time.

Researchers at Stanford have developed a method of 3D printing that promises to create prints faster, using multiple types of in a single object. Their design, published recently in Science Advances, is 5 to 10 times faster than the quickest high-resolution printing method currently available and could potentially allow researchers to use thicker resins with better mechanical and .

“This new technology will help to fully realize the potential of 3D printing,” says Joseph DeSimone, the Sanjiv Sam Gambhir Professor in Translational Medicine and professor of radiology and of chemical engineering at Stanford and corresponding author on the paper. “It will allow us to print much faster, helping to usher in a new era of digital manufacturing, as well as to enable the fabrication of complex, multi-material objects in a single step.”

Read more | >

A California university is refusing to release a cache of grisly photos of monkeys reportedly injured during experiments testing Elon Musk’s Neuralink brain implant technology, in spite of a lawsuit aiming to force the school’s hand.

In a press release, the Physicians Committee for Responsible Medicine (PCRM) advocacy group said that it had learned that the University of California, Davis is in possession of 371 photos of the experimented-upon monkeys that were subjected to Neuralink tests, which took place at the school’s veterinary lab facilities.

Earlier this year, Neuralink admitted that a fifth of the 23 rhesus macaques monkeys it used to test its brain-hacking implants had been euthanized after developing infections and malfunctions. Bolstering PCRM’s credibility, that admission came in the wake of its a complaint it filed against Neuralink.

Read more | >

“From day one, we’ve taken an aggressive public health approach to combat the spread of polio and ensure New Yorkers are protected,” Hochul said. “This declaration will bolster our ongoing efforts to protect New Yorkers against paralytic disease, prevent spread, and support our public health partners.”

Public health officials at the county level will have expanded ability to receive funding and resources for immunization clinics and conduct outreach for unvaccinated and under-vaccinated New York residents. Local health officials will be able to claim a reimbursement for these efforts, back dated to July 21 and running through Dec. 31.

“Working daily with local county health departments, our partners at CDC, and trusted leaders, the Department is working effectively to increase childhood and community vaccination rates in counties where the virus has been detected,” Bassett said. “Thanks to long-established school immunization requirements, the vast majority of adults, and most children, are fully vaccinated against polio. Our focus remains on ensuring the on-time administration of polio vaccination among young children and catching kids and adults up who are unimmunized and under-immunized in the affected areas. That work continues at full force.”

Read more | >

Scientists at the Krembil Brain Institute, part of the University Health Network, have proposed a new mechanistic model (AD2) for Alzheimer’s, looking at it not as a brain disease, but as a chronic autoimmune condition that attacks the brain.

This novel research is published today, in Alzheimer’s & Dementia.

“We don’t think of Alzheimer’s as fundamentally a disease of the . We think of it as a disease of the immune system within the brain,” says Dr. Donald Weaver, co-Director of the Krembil Brain Institute and author of the paper.

Read more | >